Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non–muscle-invasive Bladder Cancer-Reference-Cited by-同舟云学术

Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non–muscle-invasive Bladder Cancer

Published:2024-01 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Mariappan Paramananthan^ORCID,Johnston Allan,Trail Matthew,Hamid Sami,Hollins Graham,Dreyer Barend A.,Ramsey Sara,Padovani Luisa,Garau Roberta,Enriquez Julia Guerrero,Boden Alasdair,Maresca Gianluca,Simpson Helen,Hasan Rami,Sharpe Claire,Thomas Benjamin G.,Chaudhry Altaf H.,Khan Rehan S.,Bhatt Jaimin R.,Ahmad Imran,Nandwani Ghulam M.,Dimitropoulos Konstantinos,Makaroff Lydia,Shaw Johnstone,Graham Catriona,Hendry David

Publisher

Elsevier BV

Reference42 articles.

1. Bladder cancer treatment (PDQ(R)): health professional version. PDQ cancer information summaries;NIH,2002

2. Ensuring quality cancer care,1999

3. Effects of bladder cancer on UK healthcare costs and patient health-related quality of life: evidence from the BOXIT trial;Cox;Clin Genitourin Cancer,2020

4. Quality of life after bladder cancer: a cross-sectional survey of patient-reported outcomes;Catto;Eur Urol,2021

5. Bladder cancer: low adherence to guidelines in non-muscle-invasive disease;van Rhijn;Nat Rev Urol,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re: Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non–muscle-invasive Bladder Cancer;European Urology;2024-08

2. Comprehensive Urinary Proteome Profiling Analysis Identifies Diagnosis and Relapse Surveillance Biomarkers for Bladder Cancer;Journal of Proteome Research;2024-05-24

3. Contemporary Views on Performance Indicators with Audit-Feedback for Bladder Cancer Treatment;EMJ Urology;2024-05-16